Evidence-Based Medicine for Student Health Services
Robert J. Flaherty, MD
Swingle Student Health Service
Montana State University
Bozeman, MT 59717
Upper Respiratory Infection
 
Etiology Monitoring
Epidemiology Prognosis
Diagnosis Prevention
Treatment Patient Education
 
General Information
   
EBM for Student Health  
    Home Page  
   
About EBM  
  
EBM Resources 
 
Specific Conditions/Diseases
  
    
  
Etiology 
In this study the etiology of URI was as follows: 
  • Viral etiology - 69% 
    • Rhinoviruses - 52% 
    • Coronavirus OC43 or 229E infection - 8%
    • Influenza A or B virus - 6%
    • Parainfluenza virus, respiratory syncytial virus, adenovirus, enterovirus (total of single infections of each) - 7% 
  • Bacterial etiology - 3.5% 
    • Chlamydia pneumoniae - 2%
    • Haemophilus influenzae -  0.5%
    • Streptococcus pneumoniae - 0.5%
    • Mycoplasma pneumoniae - 0.5%
  • Undetermined etiology - 27.5%
 (Includes some multiple etiologies).   
Epidemiology 
No evidence is cited. 
  
Diagnosis    
No evidence is cited. 

Treatment  
Antibiotics  
Patients who had URI symptoms and positive nasopharyngeal cultures for H. influenzae, M. catarrhalis, or S. pneumoniae reported higher cure rates after amoxicillin-clavulanate. Patients who had negative cultures did not report any benefits from amoxicillin-clavulanate.  Antibiotics used to treat URIs do not prevent subsequent pneumonia.   Receiving a prescription for an antibiotic for a URI was not associated with increased patient satisfaction. Better to spend time explaining the nature of a particular illness and the physician's choice of treatment.  
Decongestants/Antihistamines  
Chlorpheniramine maleate, pseudoephedrine hydrochloride, oxymetazoline hydrochloride, phenylpropanolamine hydrochloride, ipratropium bromide, and atropine methonitrate, alone and combined with antihistamines, can improve URI symptoms in adults.  Antihistamines alone probably do not improve symptoms of URIs, and frequently cause somnolence.
  • Caveats
    • Age group: Adults
    • Type/size: Meta-analysis (7 studies - often weak)
    • Outcome measure: Symptom relief
Other Treatments 
Ipratropium bromide nasal spray may offer some minor benefit, although the response may actually be due to the saline vehicle.  
  • Caveats
    • Age group: Adults
    • Type/size: RTC of 411
    • Outcome measure: Symptom relief
  • Citations
Zinc salts lozenges do not reduce the duration of common
colds. Vitamin C, in doses of a gram or more per day, showed a consistently beneficial but generally modest therapeutic effect on duration of URI symptoms (a little less than 0.5 of a symptom day per URI episode).
  • Caveats
    • Age group: Adults
    • Type/size: Meta-analysis (30 trials)
    • Outcome measure: Duration of symptoms
    • Best dosage is not clear
 
Monitoring   
No evidence is cited.   
    
Prognosis     
No evidence is cited.     
  
Prevention      
Vitamin C, taken prophylactically even in doses of one or more grams daily for several winter months, had no consistent beneficial effect on incidence of URIs.
  • Caveats
    • Age group: Adults
    • Type/size: Meta-analysis (30 trials)
    • Outcome measure: Reduction of incidence of URIs
  
Patient Education 
The following patient education materials are consistent with the available evidence.
Rev. 10/20/01

This Web site developed and maintained by Robert J. Flaherty, MD.
Comments, additions and corrections are encouraged.